4.2 Article

The association of class IHLA alleles and antibody levels after a single dose of measles vaccine

Journal

HUMAN IMMUNOLOGY
Volume 64, Issue 1, Pages 103-109

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0198-8859(02)00741-3

Keywords

Genes; MHC class I; measles vaccine; antibody formation

Categories

Funding

  1. NCRR NIH HHS [M01-RR-00585-25] Funding Source: Medline
  2. NIAID NIH HHS [N01-AI-45240, R01-2AI-33144] Funding Source: Medline
  3. NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033144, N01AI045240] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Despite the success of the current measles vaccine in controlling disease in industrialized countries, the importance of vaccine failure has become increasingly apparent. Our objective was to determine if associations exist between seronegativity after measles vaccination and class I human leukocyte antigen (HLA) alleles. We undertook a cross-sectional observational study in Rochester, Minnesota, with 242 school-age children previously recruited from a communitywide seroprevalence study. We studied two groups of subjects: 72 were seronegative (EIA less than or equal to0.8 after a single dose of measles vaccine) and 170 were sempositive (enzyme immunoassy [EIA] greater than or equal to1.0 after one dose). We used the resources of Mayo Clinic's tissue typing laboratory for serotyping class I HLA-A and HLA-B alleles via microlymphocytotoxicity assays. We found no statistically significant associations with class I HLA-A but did find associations with class I HLA-B, which includes alleles associated with seronegativity (138, 1313, and 1344) and those associated with sempositivity (137 and 1351). Elucidation of the specific peptide-HLA complex interactions that lead to varying or failed immune responses may provide fertile groundwork for improved vaccines that can overcome limitations of the current live, attenuated measles vaccine. (C) American Society for Histocompatibility and Immunogenetics, 2003. Published by Elsevier Science Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available